Ren, Yunzhao R.
United States Food and Drug Administration · Center for Drug Evaluation and Research
3 papers on CoChat
Most cited papers
- Verified
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
Zhang, H., Qian, D. Z., Tan, Y. S., Lee, K., Gao, P., Ren, Y. R., Rey, S., Hammers, H., Chang, D., Pili, R., et al. (2008) · Proceedings of the National Academy of Sciences
Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in Cancer
Cited by 624
- Verified
Cholesterol trafficking is required for mTOR activation in endothelial cells
Xu, J., Dang, Y., Ren, Y. R., & Liu, J. O. (2010) · Proceedings of the National Academy of Sciences
PI3K/AKT/mTOR signaling in cancerCholesterol and Lipid Metabolism
Cited by 209
- Verified
Human radiolabeled mass balance studies supporting the FDA approval of new drugs
Ramamoorthy, A., Bende, G., Chow, E. C. Y., Dimova, H., Hartman, N., Jean, D., Pahwa, S., Ren, Y., Shukla, C., Yang, Y., et al. (2022) · Clinical and Translational Science
Pharmacogenetics and Drug MetabolismPharmaceutical studies and practices
Cited by 40
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free